Portfolio Alerts Watch List Cart

Healthcare

Refine Search


Product Compare (0)
A
Ambey Laboratories Ltd
Score 48/100• Risky
Ambey Laboratories Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health77/100
Valuation 80/100 · PB 1.3086
Technical Avoid
1M -5.602% 6M 4.297% 1Y -33.527%
Confidence100%
No promoter pledgeReasonable PB valuation
Weak ROEThin margins
#271
View details ➜
A
Amanta Healthcare Ltd
Score 48/100• Risky
Amanta Healthcare Ltd presents a risky investment opportunity due to inconsistent growth and valuation concerns.
Company’s Health58/100
Valuation 40/100 · PB 4.3969
Technical Avoid
1M -7.783% 6M -13.94% 1Y -13.94%
Confidence100%
No promoter pledge
Weak ROEHigh debt/equity
#272
View details ➜
A
Adeshwar Meditex Ltd
Score 48/100• Risky
Adeshwar Meditex Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health64/100
Valuation 100/100 · PB 0.7224
Technical Watch
1M 22.032% 6M 23.333% 1Y -22.917%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#273
View details ➜
A
Amwill Health Care Ltd
Score 48/100• Risky
Amwill Health Care Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
Company’s Health98/100
Valuation 80/100 · PB 1.5607
Technical Avoid
1M -2.439% 6M -42.382% 1Y -42.091%
Confidence100%
Low leverage (D/E)No promoter pledge
#274
View details ➜
A
Alivus Life Sciences Ltd
Score 48/100• Risky
Alivus Life Sciences Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health93/100
Valuation 40/100 · PB 3.9384
Technical Avoid
1M -0.564% 6M -16.916% 1Y -14.449%
Confidence100%
Low leverage (D/E)No promoter pledge
#275
View details ➜
A
Albert David Ltd
Score 48/100• Decent
While Albert David Ltd operates in a promising sector, its inconsistent growth and valuation concerns suggest caution for investors.
Company’s Health66/100
Valuation 80/100 · PB 1.2358
Technical Avoid
1M 8.1% 6M 2.176% 1Y -38.682%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#276
View details ➜
G
Godavari Drugs Ltd
Score 48/100• Risky
Godavari Drugs Ltd presents several risks with inconsistent growth and weak market sentiment, making it a risky investment at this time.
Company’s Health52/100
Valuation 80/100 · PB 1.5146
Technical Avoid
1M 1.995% 6M -2.045% 1Y -29.056%
Confidence100%
Reasonable PB valuation
Weak ROEPromoter pledge present
#277
View details ➜
G
Global Longlife Hospital and Research Ltd
Score 48/100• Risky
The stock presents several risks with limited growth potential and profitability concerns, making it a risky investment.
Company’s Health50/100
Valuation 100/100 · PB 0.9297
Technical Avoid
1M -2.105% 6M 3.13% 1Y -26.106%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#278
View details ➜
G
Glenmark Pharmaceuticals Ltd
Score 48/100• Risky
Glenmark Pharmaceuticals presents several risks with inconsistent growth and profitability metrics, alongside governance concerns. Caution is advised for potential investors.
Company’s Health63/100
Valuation 20/100 · PB 6.0311
Technical Avoid
1M -4.227% 6M 37.542% 1Y 11.605%
Confidence100%
Low leverage (D/E)No promoter pledge
Thin margins
#279
View details ➜
G
GKB Ophthalmics Ltd
Score 48/100• Risky
GKB Ophthalmics Ltd shows potential in a growing sector, but faces significant risks and inconsistencies in financial performance.
Company’s Health60/100
Valuation 100/100 · PB 0.6044
Technical Avoid
1M -2.572% 6M -4.164% 1Y -34.933%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#280
View details ➜
G
Gennex Laboratories Ltd
Score 48/100• Risky
Gennex Laboratories Ltd shows potential but faces significant risks and inconsistencies in growth and profitability.
Company’s Health59/100
Valuation 60/100 · PB 2.0514
Technical Watch
1M 44.288% 6M 25.997% 1Y -20.243%
Confidence100%
Low leverage (D/E)Healthy profit margins
Weak ROEPromoter pledge present
#281
View details ➜
G
Ganga Pharmaceuticals Ltd
Score 48/100• Risky
Ganga Pharmaceuticals Ltd shows potential in a growing sector, but faces challenges in profitability and market sentiment.
Company’s Health48/100
Valuation 80/100 · PB 1.2105
Technical Avoid
1M — 6M 32.727% 1Y -25.396%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#282
View details ➜
E
Eris Lifesciences Ltd
Score 48/100• Decent
Eris Lifesciences Ltd shows decent potential with consistent growth and profitability metrics, but faces challenges in valuation and execution risks.
Company’s Health69/100
Valuation 20/100 · PB 6.6267
Technical Avoid
1M 1.415% 6M 6.575% 1Y 20.296%
Confidence100%
Healthy profit marginsDecent revenue growth
Weak ROEPromoter pledge present
#283
View details ➜
E
Emmessar Biotech and Nutrition Ltd
Score 48/100• Risky
Emmessar Biotech and Nutrition Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health68/100
Valuation 60/100 · PB 2.0108
Technical Avoid
1M -3.462% 6M -10.447% 1Y -27.211%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#284
View details ➜
E
Eiko Lifesciences Ltd
Score 48/100• Risky
Eiko Lifesciences Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health84/100
Valuation 80/100 · PB 1.3562
Technical Avoid
1M -1.07% 6M 10.231% 1Y -15.238%
Confidence100%
Low leverage (D/E)No promoter pledge
Thin margins
#285
View details ➜
Showing 271 to 285 of 301 (21 Pages)